![Two people who received Pfizer's respiratory syncytial virus vaccine during a clinical trial were later diagnosed with Guillain-Barre syndrome](https://localnews8.b-cdn.net/2023/02/hypatia-h_edd290f9d54eca3a069c578a47b84fae-h_e2d305eb7005e12cb283140d7cfdbc73-300-375x225.jpg)
Rare neurological condition is ‘important potential risk’ of Pfizer’s RSV vaccine, FDA says
By Janelle Chavez, CNN Two people who received Pfizer’s respiratory syncytial virus (RSV) vaccine during a clinical trial were later diagnosed…
Continue Reading